Clinical trials: Follicular Lymphoma Grade 3B
Grade 3b Follicular Lymphoma
An Italian Experience on Grade 3b Follicular Lymphoma
Study purpose is to evaluate baseline clinical data, outcome after front-line Rituximab containing chemotherapy and survival in patients with grade 3b Follicular Lymphoma.
- Trial name
- FL3b-Oss-2015 (NCT02927717)
- Volunteers
- 60 people
- Sponsor
- A.O.U. Città della Salute e della Scienza
Diffuse Large B-Cell Lymphoma (DLBCL), Follicular NHL Grade 3b
A Multicentre, Randomized Phase III Study of Rituximab as Maintenance Treatment Versus Observation in Patients With Aggressive B-cell Lymphoma: NHL-13
This is a randomized, open label, phase III study to evaluate the ability of rituximab maintenance therapy to prolong event-free survival in aggressive NHL.
- Trial name
- NCT00400478
- Testing
- Rituximab
- Where
- 131 sites in Australia, Austria and 24 more
- Volunteers
- 683 people
- Sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
Diffuse Large B-cell Lymphoma, Follicular Grade 3B Lymphoma
Early Treatment Stratification Based on PET Scan Response to Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
The aim of the study is to evaluate the event free survival at three years in patients with diffuse large B-cell lymphoma with poor prognostic factors receiving R-MegaCHOP as induction therapy.
- Trial name
- R-MEGACHOP (NCT01361191)
- Testing
- R-MEGACHOP
- Where
- 19 sites in Spain
- Volunteers
- 71 people
- Sponsor
- Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea